Understanding how brain cells called microglia affect memory after brain injury
Thalamic microglia drive cognitive impairment after cortical injuries
This research explores how certain brain cells in a specific area of the brain might contribute to memory problems after a brain injury, which could help people at risk for dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11121095 on NIH RePORTER |
What this research studies
After a brain injury, many people face a higher chance of developing memory issues and conditions like Alzheimer's disease. We know that special brain cells called microglia become very active in a brain region called the thalamus after an injury, and this activity is linked to memory problems. Our team has found that these thalamic microglia play a unique role in memory difficulties in animal models. By understanding how these cells work, we hope to find new ways to protect memory and brain function after an injury.
Who could benefit from this research
Good fit: This foundational research is relevant for individuals who have experienced a traumatic brain injury and are concerned about future cognitive decline or dementia.
Not a fit: Patients without a history of brain injury or related cognitive impairment are unlikely to directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that prevent or reduce cognitive impairment and dementia risk in individuals who have experienced a brain injury.
How similar studies have performed: While human imaging studies have observed microglial activation, this research explores a novel and specific role of thalamic microglia in cognitive impairment following brain injury.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Kano, Shinichi — University of Alabama at Birmingham
- Study coordinator: Kano, Shinichi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.